Cigna Group CI
272.01
6.51
2.45%
as of 25 Sep
- Market cap
- $69.9B
- P/E
- 11.3×
Follow CI
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cigna Group (CI) P/E ratio
As of 25 September 2026, Cigna Group (CI) trades at a P/E ratio of 11.3×. Over the past ten years it has ranged from 8.1× (November 2021) to 33.8× (October 2024); the current reading is higher than 9% of that period. That is below the Healthcare Plans industry median of 23.8× and below the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 12.4× | (45.00%) |
| FY2024 | 22.6× | 26.52% |
| FY2023 | 17.8× | 18.59% |
| FY2022 | 15.0× | 3.07% |
| FY2021 | 14.6× | 61.95% |
| FY2020 | 9.0× | (40.84%) |
| FY2019 | 15.2× | (14.22%) |
| FY2018 | 17.7× | (23.50%) |
| FY2017 | 23.2× | 23.09% |
| FY2016 | 18.9× | 3.57% |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 11.4× | 0.87% |
| Mar 2026 | 11.3× | (8.87%) |
| Dec 2025 | 12.4× | (2.41%) |
| Sep 2025 | 12.7× | (29.54%) |
| 42 more quarters | Free account |
Against its own ten years
Low 8.1×
High 33.8×
Ten-year median
16.3×
Current reading's percentile
9
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| MOH Molina Healthcare, Inc compare | n/m |
| CNC Centene Corporation compare | n/m |
| CI Cigna Group | 11.3× |
| OSCR Oscar Health, Inc. compare | 17.3× |
| ELV Elevance Health, Inc. compare | 17.6× |
| CVS CVS Health Corporation compare | 23.3× |
| UNH UnitedHealth Group Incorporated compare | 24.2× |
| HUM Humana Inc. compare | 37.4× |
| Healthcare Plans industry median | 23.8× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CI
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement